Vitamin D deficiency and multicultural Australia

Paul Glendenning, Rebecca S Mason and Terrence H Diamond
Med J Aust 2002; 176 (5): . || doi: 10.5694/j.1326-5377.2002.tb04389.x
Published online: 4 March 2002

To the Editor: In a recent editorial, Mason and Diamond state that ergocalciferol (vitamin D2) is bioequivalent to cholecalciferol (vitamin D3) and that 1000 IU/day of ergocalciferol is sufficient for the treatment of vitamin D deficiency.1 Both statements are contentious. Although ergocalciferol (vitamin D2) is the only single prohormonal form of vitamin D available on prescription in Australia, there are three reasons to be cautious about the use and dose equivalence of ergocalciferol (vitamin D2) compared with cholecalciferol (vitamin D3).

  • Paul Glendenning
  • Rebecca S Mason
  • Terrence H Diamond

  • 1 Department of Core Clinical Pathology and Biochemistry, Royal Perth Hospital, Perth, WA.
  • 2 Department of Physiology, University of Sydney, NSW 2006.
  • 3 Department of Endocrinology, St George Hospital, Kogarah, NSW.

Competing interests:

None declared.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.